Ernexa Therapeutics Inc. Capital Leases, Balance Sheet, Assets by Major Class, Net
Ernexa Therapeutics Inc. (ERNA) had Capital Leases, Balance Sheet, Assets by Major Class, Net of $81.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-22.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesBalanceSheetAssetsByMajorClassNet · last filed 2019-03-22
- 2018-12-31: Capital Leases, Balance Sheet, Assets by Major Class, Net $81.00K.
- 2017-12-31: Capital Leases, Balance Sheet, Assets by Major Class, Net $290.00K.
- 2016-12-31: Capital Leases, Balance Sheet, Assets by Major Class, Net $393.00K.
- 2015-12-31: Capital Leases, Balance Sheet, Assets by Major Class, Net $202.00K.
| Period end | Capital Leases, Balance Sheet, Assets by Major Class, Net |
|---|---|
| 2018-12-31 | $81.00K 10-K · filed 2019-03-22 |
| 2017-12-31 | $290.00K 10-K · filed 2019-03-22 |
| 2016-12-31 | $393.00K 10-K · filed 2018-03-09 |
| 2015-12-31 | $202.00K 10-K · filed 2017-03-09 |
| 2014-12-31 | $43.00K 10-K · filed 2016-03-15 |
| 2013-12-31 | $63.00K 10-K · filed 2015-03-27 |
| 2012-12-31 | $129.00K 10-K · filed 2014-03-31 |
| 2011-12-31 | $420.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |